DGX analyst estimates
Quest Diagnostics (DGX) analyst ratings, the average price target and its range, and every firm's latest call.
DGX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 23, 2026 | Robert W. Baird | Quest Diagnostics price target raised to $262 from $260 at Baird | $262.00 |
| Oct 19, 2026 | UBS | Quest Diagnostics price target raised to $250 from $245 at UBS | $250.00 |
| Oct 7, 2026 | Barclays | Quest Diagnostics price target raised to $260 from $250 at Barclays | $260.00 |
| Sep 21, 2026 | Truist Financial | Quest Diagnostics price target raised to $260 from $250 at Truist | $260.00 |
| Sep 8, 2026 | UBS | Quest Diagnostics price target raised to $245 from $232 at UBS | $245.00 |
| Jul 29, 2026 | Argus Research | Quest Diagnostics price target raised to $260 from $225 at Argus | $260.00 |
| Jul 24, 2026 | Robert W. Baird | Quest Diagnostics price target raised to $255 from $236 at Baird | $255.00 |
| Jul 24, 2026 | UBS | Quest Diagnostics price target raised to $232 from $220 at UBS | $232.00 |
| Jul 23, 2026 | Jefferies | Quest Diagnostics price target raised to $245 from $225 at Jefferies | $245.00 |
| Jul 23, 2026 | Barclays | Quest Diagnostics price target raised to $250 from $230 at Barclays | $250.00 |
| Jul 13, 2026 | Robert W. Baird | Quest Diagnostics price target raised to $236 from $232 at Baird | $236.00 |
| Apr 21, 2026 | Jefferies | Quest Diagnostics price target raised to $225 from $220 at Jefferies | $225.00 |
| Apr 21, 2026 | Evercore ISI | Quest Diagnostics price target raised to $225 from $210 at Evercore ISI | $225.00 |
| Apr 8, 2026 | Evercore ISI | Quest Diagnostics target cut, added to 'Tactical Outperform' list at Evercore | $210.00 |
| Feb 12, 2026 | Mizuho Securities | Quest Diagnostics price target raised to $235 from $210 at Mizuho | $235.00 |
- 9 firms rate DGX: 3 buy, 6 hold, 0 sell.
- The average price target is $256.17 from 6 analysts, from $245.00 to $262.00.
Updated 2026-11-02 23:11 UTC